Geoffrey G Emerson, M.D., Ph.D., Preview of 2024 ASRS meeting
Geoffrey G. Emerson of Retina Consultants of Minnesota and medical director at the Phillips Eye Institute in Minneapolis and an associate adjunct professor at the University of Minnesota, previews the 2024 annual meeting of the American Society of Retina Specialists (ASRS) starting Wednesday, July 17, in Stockholm, Sweden.
Geoffrey G. Emerson, M.D., Ph.D., of Retina Consultants of Minnesota and medical director at the Phillips Eye Institute in Minneapolis and an associate adjunct professor at the University of Minnesota, previews the 2024 annual meeting of the American Society of Retina Specialists (ASRS) starting Wednesday, July 17, in Stockholm, Sweden.
Emerson is the program chair of ASRS and helped organize the meeting's content.
In this video interview with Managed Healthcare Executive, he says new themes to the research and presentations at this year's meeting include artificial intelligence, retina complications associated with myopia, and continuing from last year's meeting, geographic atrophy and two new treatments for it, Syfovre (pegacetacoplan) and Izervay (avancincaptad pegol).
Changes to Susvimo Port Delivery System Explained | ASRS 2024
July 22nd 2024Dante J. Pieramici, M.D., of the California Retina Research Foundation, explains changes made to the Susvimo port delivery system that are designed. to prevent the septum dislodgment that led to Genentech pulling the product off the market.
Read More
Results from retrospective real-world studies presented at American Society of Retina Specialists annual meetiing put the risk of retinal vasculitis from Syfovre at 1 in 1,330 patients. But other results presented at the meeting supplied evidence that Syfovre fends off vision loss caused by geographic atrophy, an advanced form of dry age-related macular degeneration.
Read More
